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Embryonic stemcells (ESCs) are apparently homoge-
neous self-renewing cells, but we observed hetero-
geneous expression of Stella in ESCs, which is
a marker of pluripotency and germ cells. Here we
show that, whereas Stella-positive ESCs were like
the inner cell mass (ICM), Stella-negative cells were
like the epiblast cells. These stateswere interchange-
able, which reflects themetastability and plasticity of
ESCs. The established equilibrium was skewed re-
versibly in the absence of signals from feeder cells,
which caused a marked shift toward an epiblast-like
state, while trichostatin A, an inhibitor of histone
deactelylase, restored Stella-positive population.
The two populations also showed different histone
modifications and striking functional differences, as
judged by their potential for differentiation. The
Stella-negative ESCs were more like the postimplan-
tation epiblast-derived stem cells (EpiSCs), albeit the
stella locus was repressed by DNAmethylation in the
latter, which signifies a robust epigenetic boundary
between ESCs and EpiSCs.
INTRODUCTION
Mouse embryonic stem cells (ESCs) exhibit a degree of similarity
with three different transient cell populations in the mouse em-
bryo: the inner cell mass (ICM) of blastocysts, the epiblast cells
of early postimplantation embryos, and primordial germ cells
(PGCs), which includes expression of pluripotency marker
genes, such as Oct4 (Chambers and Smith, 2004; Pesce et al.,
1998; Surani et al., 2007; Zwaka and Thomson, 2005). However,
unlike the cells in vivo, ESCs retain pluripotency and exhibit the
capacity for indefinite self-renewal, while the cells in vivo un-
dergo differentiation according to a strict developmental pro-
gram. As long as ESCs are cultured in an appropriate medium,
such as the one containing leukemia inhibitory factor (LIF) and
with either serum or bone morphogenetic protein 4 (BMP4),
they can undergo self-renewal without compromising pluripo-
tency (Ying et al., 2003). For this reason, ESCs are generallyregarded as a homogeneous group of cells in the majority of
studies.
However, the precise provenance of ESCs for which there is
no strict in vivo equivalent remains to be fully elucidated. Based
on some recent studies, it has been suggested that germ cells
may be the closest in vivo equivalent of ESCs (Zwaka and Thom-
son, 2005), partly because expression of Stella has been re-
ported in both mouse and human ESCs, albeit heterogeneously
(Clark et al., 2004; Payer et al., 2006). Stella, a definitivemarker of
the germ cell lineage, is, however, first observed in preimplanta-
tion embryos. Thereafter, Stella is repressed in the epiblast
(Payer et al., 2006; Sato et al., 2002) and subsequently re-
expressed only following specification of PGCs (Payer et al.,
2006). Other proteins such as Pecam1, Nanog, and SSEA1
also exhibit heterogeneous expression in undifferentiated
ESCs (Chambers et al., 2007; Cui et al., 2004; Furusawa et al.,
2004; Payer et al., 2006; Toyooka et al., 2008). Thus, while het-
erogeneity is a hallmark of ESCs, it remains to be fully elucidated
how this is compatible with pluripotency and self-renewal.
In this study, we set out to investigate the nature of Stella-
expressing cells in undifferentiated ESCs. We demonstrate that
Stella-positive ESCs are closely related to the ICM and not to
the epiblast or PGCs. Moreover, cultured under conditions that
maintain pluripotency, the proportion of Stella-positive cells re-
mained relatively constant, while they were able to reversibly
convert to Stella-negative ESCs. Expression of stella is regulated
by chromatin-based modifications in ESCs, which can respond
to both the environmental and epigenetic cues. We propose
that while undifferentiated ESCs undergo self-renewal, they are
in a highly dynamic state as they continuously fluctuate between
an ICM- and epiblast-like phenotype. By contrast, stella is ro-
bustly repressed by DNA methylation in pluripotent stem cells
derived from postimplantation epiblast cells (EpiSCs), which do
not readily revert to an ICM-like state.
RESULTS
The Population of Stella-GFP-Positive Cells Remains
Relatively Constant
We previously generated two stella-gfp transgenic ESC lines
(SH10.10 and BAC9) with different lengths of the stella flanking
sequences coupled to a gene for green fluorescent protein
(GFP) as the reporter (Payer et al., 2006). In these ESCs,
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in a subset of ESCs (Figures 1A–1C). Similar heterogeneous ex-
pression of Stella was also confirmed in nontransgenic ESCs by
immunsostaining (data not shown). Notably, cells with expres-
sion of Stella-GFP coincided significantly with those observed
for endogenous Stella expression. For example, this was the
case in 126 of 141 (89%) randomly chosen ESCs, although
some Stella-positive cells were negative for Stella-GFP (5%),
and some strongly Stella-GFP-positive cells (6%) expressed
Stella only weakly. Fluorescence-activated cell sorting (FACS)
consistently revealed that around 20%–30% of ESCs were
Stella-GFP positive under our culture conditions, irrespective
of the passage number (Figure 1D). However, the exact propor-
tion of Stella-GFP-positive cells occasionally deviated from this
range, as they are susceptible to slight differences in culture con-
ditions (data not shown). These observations were made
whether we used ESCs from stella-gfp BAC9 or from stella-gfp
SH10.10 transgenic mice, except that the fluorescence activity
of Stella-GFP in BAC9 ESCs was weaker (Figure 1D), which is
most likely the result of the integration of a different copy number
of transgenes in the genome. For convenience, we used stella-
gfp SH10.10 ESCs in the rest of the studies described here.
Stella-GFP-Positive Population Is Enriched
in ICM-Specific Markers
Next, we examined transcription profiles of the Stella-GFP-pos-
itive and -negative populations by quantitative reverse polymer-
ase chain reaction (Q-PCR). Notably, we found that the two frac-
tions clearly differed in the levels of expression of Fgf5, a marker
of pluripotent epiblast cells of early postimplantation embryos,
which is not expressed in the ICM (Pelton et al., 2002; Rathjen
et al., 1999). Furthermore, Gbx2 was also detected at a higher
level in the Stella-GFP-negative cells, and like Fgf5, Gbx2 is
also upregulated in the primitive ectoderm cells soon after im-
plantation (Figure 2A) (Chapman et al., 1997; Kurimoto et al.,
2006). By contrast, the Stella-GFP-positive population was
slightly enriched in Pecam1 and Zfp42/Rex1 transcripts, which
are preferentially expressed in ICM compared to the epiblast
(Figure 2A) (Pelton et al., 2002; Robson et al., 2001). Genes such
as alphafetoprotein and collagen type IV that are upregulated in
differentiated ESCs were not detectable in either of the two pop-
ulations (data not shown), indicating that the Stella-GFP-negative
population is not representative of differentiating ESCs.
Single-Cell Analysis
The above analysis was conducted on the two FACS-sorted cell
populations, which would mask the extent of variations among
individual cells. In addition, whereas Stella-GFP expression in
ESCs showed extensive overlap with the endogenous expres-
sion of Stella, they do not coincide completely (Figures 1A–1C
and 2A). Therefore, we decided to further investigate the nature
of heterogeneity among the ESCs by examining gene expres-
sions in 87 randomly selected single ESCs. Q-PCR analysis re-
vealed variable stella transcripts in 63 (72.4%) cells (Figure 2B),
among which we found 26 (29.9%) Gfp-expressing cells.
Notably, Gfp was detected predominantly in cells with high
expression of stella (Figure 2B), which is consistent with the
20%–30% of Stella-positive cells we detected by immunostain-
ing. Among these, 15 of 26 cells showed high stella expression
392 Cell Stem Cell 3, 391–401, October 9, 2008 ª2008 Elsevier Inc.(stella-high; 57.8%), and 9 of 26 belonged to the stella-low group
(34.6%) (Figure 2B). The differences in the percentage of cells
with the stella transcript and those positive for the protein might
be caused by translational regulation of stella transcript. It is pos-
sible that translational regulation is an important general feature
of ESCs. Nevertheless, these results demonstrate that the num-
ber of stella transcripts in individual cells was variable, but virtu-
ally all the stella-Gfp-positive cells (92.9%, 26 of 28) were present
within the group with high stella transcripts (Figure 2B).
Next, we extended our single-cell Q-PCR analysis to further
assess expression of the other key marker genes. In agreement
with the data from the FACS-sorted populations, we detected
Fgf5 expression predominantly among the stella-negative cells.
By contrast, most Pecam1-expressing cells were among those
with expression of stella, which also showed higher expression
of Zfp42/Rex1 (Figure 2B). Furthermore, it is of interest that
expression of Gbx2 was detected among the stella-low and
stella-negative cells, which is consistent with the in vivo expres-
sion ofGbx2 that starts to increase in the E4.5 primitive ectoderm
Figure 1. Heterogeneous Expression of Stella in Undifferentiated
ESCs
(A–C) Immunoflurescence analysis of Stella-GFP (A) and endogenous Stella (B)
expression in transgenic stella-gfp SH10.10 ESCs and their merged images
with DAPI (C). Scale bar, 50 mm.
(D) Percentage of Stella-GFP-positive cells in control ces3 ESCs (ESWT; left),
stella-gfp SH10.10 (middle), and stella-gfp BAC9 (right) transgenic lines. Num-
bers above the gates indicate the percentage of the GFP-positive cells plotted
in each dot plot. Numbers described in upper left indicate the passage num-
ber.
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et al., 2006). It is striking that the average numbers of Nanog
and Sox2 transcripts were also significantly lower in stella-nega-
tive cells compared to the stella-positive cells (0.01 < p < 0.05)
(Figure 2B), which may reflect a decrease in these transcripts
in vivo in the E4.5 primitive ectoderm and epiblast cells of mid-
streak embryos, respectively (Avilion et al., 2003; Chambers
et al., 2003). By contrast, Oct4 transcripts were detected uni-
formly in all cells, which is the case in vivo in ICM and epiblast
cells. Notably, these results indicated that the developmentally
regulated genes are not expressed stochastically among
ESCs, as their expression seems to reveal an adherence to the
in vivo developmental program.
Consistent with the Q-PCR analyses of single cells, the entire
population of Stella-GFP-positive ESCs was contained within
Figure 2. Differential Gene Expression in
Stella-Positive and Stella-Negative Popula-
tions of stella-gfp SH10.10 ESCs
(A) Q-PCR analysis of each gene in FACS-sorted
Stella-GFP-positive and Stella-GFP-negative
populations. Relative levels of each gene expres-
sion are estimated by referring to the value of
Gapdh. Themean values are calculated from three
independent experiments.
(B) Q-PCR analysis using randomly selected single
cells from stella-gfp ESCs. The left graph shows
the putative number (log10) of transcript in each
single cell. Three populations, Stellahigh, Stellalow,
and Stellanegative, were identified and are set apart
by broken lines. The right graph shows the aver-
age number of transcripts in each population.
the Pecam1-positive population by
FACS analysis (see Figure S1 available
online).Pecam1 is a developmentally reg-
ulated gene that is homogeneously ex-
pressed in the ICMandcompletely absent
from the epiblast (Figure S1 and Robson
et al., 2001). This being the case, it is clear
that the Stella-GFP-positive cells are con-
tained within these ICM-like cells. By
contrast, expression of SSEA1, which
also shows heterogeneous expression in
ESCs (Cui et al., 2004; Furusawa et al.,
2004), was detected in both the Stella-
GFP-positive and Stella-GFP-negative
cells (Figure S1). However, unlike Pe-
cam1, there is heterogeneous expression
of SSEA1 in both the ICM and epiblast
cells (Cui et al., 2004; Furusawa et al.,
2004). We observed that the Stella-GFP-
positive cells were detected within the
SSEA1-positive as well as the SSEA1-
negative population at comparable levels
(17.4% versus 11.0%) (Figure S1). Immu-
nofluorescence analysis confirmed that
Stella-GFP-positive cells did not entirely
overlap with the SSEA1-positive cells
(Figure S1). These results again empha-
size that heterogeneity among ESCs has a basis in the inherent
developmental program in vivo.
The Subpopulations of ESCs Are Interchangeable
Next we asked how the relatively stable population of 20%–30%
Stella-GFP-positive cells is maintained among the ESCs, for
which there are at least two possibilities: either they are in a state
of flux and interchange continuously between positive and neg-
ative states while maintaining a constant ratio, or they give rise
only to descendants of the same type. To distinguish between
these possibilities, FACS-sorted Stella-positive and Stella-
negative ESCs populations were cultured and analyzed sepa-
rately. To avoid contamination of cells that express endogenous
stella but no Gfp transcripts, we used a Stella-GFP-negative/
Pecam1-negative population, since single-cell analysis revealed
Cell Stem Cell 3, 391–401, October 9, 2008 ª2008 Elsevier Inc. 393
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(A) Stella-GFP-positive/Pecam1-positive (green) and Stella-GFP-negative/Pecam1-negative (yellow) FACS-sorted stella-gfp ESCs were cultured for 7 days. The
percentage of cells with Stella-GFP expression was analyzed on days 0, 3, 5, and 7. Gating was determined independently at each time point using unsorted
stella-gfp ESCs analyzed in parallel as a reference. The percentage of gated cells is given in the upper corner of each dot plot.
(B) Summary of phenotypic changes in Stella-GFP-positive/Pecam1-positive and Stella-GFP-negative/Pecam1-negative cells. Note that the Stella-GFP-posi-
tive/Pecam1-positive cells (green cells) revert to the original proportionmore quickly than the Stella-GFP-negative/Pecam1-negative (yellow) cells. Cells depicted
with white cytoplasm indicate Stella-GFP-negative/Pcam1-positive cells.
(C) Clonal analysis of Stella-GFP-positive/Pecam1-positive and Stella-GFP-negative/Pecam1-negative FACS-sorted stella-gfp ESCs. Cells were expanded for
9 days and the percentage of Stella-GFP-positive cells in each independent clone (n = 64) determined by FACS analysis. The averaged percentage is shown in
each graph.
(D) Different rate of colony formation of Stella-GFP-positive/Pecam1-positive and Stella-GFP-negative/Pecam1-negative stella-gfp ESCs. The average numbers
of colonies fromStella-GFP-positive/Pecam1-positive and Stella-GFP-negative/Pecam1-negative FACS-sorted stella-gfp ESCs are shown. Themean values are
calculated from three independent experiments.that cells that do not express endogenous stella were enriched
within the double-negative population. Remarkably, after 3 days
of culture, approximately 50% of the cells in both the individual
fractions were found to be Stella-GFP negative/Pecam1 positive
(Figure 3A). We consider these cells to be phenotypically closest
to the two original isolated FACS-sorted populations described
above. Indeed, these individual cultures were eventually fully
restored to the original state of about 20%–30% Stella-GFP-
positive cells that we first encountered among the stella-gfp
ESCs. Interestingly, the Stella-GFP-positive/Pecam1-positive
population reverted to the original state faster than the Stella-
GFP-negative/Pecam1-negative cells, which occurred within 5
and 7 days of culture, respectively (Figures 3A and 3B). These
results show that the FACS-sorted populations of ESCs repre-
senting the two extreme populations are interchangeable. More-
over, the two individual groups of cells first generated a large
proportion of Stella-GFP-negative/Pecam1-positive cells, which
394 Cell Stem Cell 3, 391–401, October 9, 2008 ª2008 Elsevier Inc.were in turn followed by the generation of cell types that pro-
gressively departed further away from the original FACS-sorted
Stella-GFP-positive/Pecam1-positive and Stella-GFP-negative/
Pecam1-negative cell types, respectively. These observations
suggest an adherence to an intrinsic program during their inter-
conversion rather than a stochastic change in gene expression.
To exclude the possibility that the results could be influenced
by the reciprocal contamination of the two cell populations, ESC
subclones (n = 64) derived from FACS-sorted single Stella-GFP-
positive/Pecam1-positive or Stella-GFP-negative/Pecam1-neg-
ative cells were analyzed at 9 days after FACS sorting. Clonal
analysis revealed that both sets of cells could generate the recip-
rocal set of cells as in the parental cell lines (Figure 3C), except
that there was a lower average percentage of Stella-GFP-posi-
tive cells detected from the latter subclones, which is consistent
with the relatively less efficient generation of the reciprocal cell
types as described previously. Moreover, the clonal analysis
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Locus and Modulation of Stella-GFP-Posi-
tive Cells
(A) ChIP analysis of histone modifications in the
stella locus. Genomic DNAs from FACS-sorted
Stella-GFP-positive/Pecam1-positive or Stella-
GFP-negative/Pecam1-negative cells were immu-
noprecipitated with the antibodies as indicated
and were then subjected to Q-PCR using a primer
set specific to the endogenous genomic locus en-
coding the start codon of Stella. Levels of histone
modifications were estimated by dividing with the
input value (see the Experimental Procedures).
(B) Bisulfite sequencing profiles of DNA methyla-
tion of the stella locus. CpG sequences are shown
with filled (methylated) and open (unmethylated)
circles. Gaps in the methylation profiles represent
mutated or missing CpG sites. The numbers under
the bisulfite sequencing profiles show the percent-
ages of methylated CpG.
(C) FACS analysis of Stella-GFP-positive cells un-
der various conditions. Shown are the percent-
ages of Stella-GFP-positive cells after culturing
stella-gfp ESCs without MEFs (upper left), followed by reculturing them on MEFs in chemically defined medium (upper right) or exposing them to TSA (lower
left) or 5-aza (lower right) in the absence of MEFs.
(D) Morphology of the colonies of stella-gfp ESCs cultured with TSA. Images show the change in morphology of the stella-gfp ESC colonies cultured without MEF
(left) and then following addition of TSA (right). Note the relatively more compact ESC colonies in the latter. Windows in each image represent Stella-GFP in a col-
ony. Scale bar, 50 mm.also showed less-efficient plating of Stella-GFP-negative/Pe-
cam1-negative ESCs, which formed fewer colonies compared
to the cells of the opposite phenotype (Figure 3D). Thus, while
the overall population of Stella-positive ESCs is maintained
through mutual conversion of positive and negative cells, the
efficiency of the process clearly differs. We reason that the con-
version of Stella-positive/Pecam1-positive cells into Stella-neg-
ative/Pecam1-negative cells follows an inherent developmental
program from ICM toward epiblast, whereas the reciprocal con-
version is contrary to the normal developmental program in vivo.
This could account for the slower conversion rate of the latter.
Epigenetic Regulation of Metastable Stella
Expression in ESCs
The intermittent expression of Stella in ESCs indicates that these
pluripotent stem cells are probably in a metastable state, which
should be reflected in their epigenetic states. We therefore
examined histone modifications and DNA methylation in the
endogenous genomic DNA sequences surrounding the start co-
don of Stella. We found that the Stella-GFP-positive ESCs dis-
played a relative enrichment of acetylated histone H3 lysine 9
(H3K9ac) and trimethylated H3K4 (H3K4me3), which are a hall-
mark of an active gene, compared to the levels in Stella-GFP-
negative/Pecam1-negative ESCs (Figure 4A). The levels of trime-
thylation of H3K27 (H3K27me3), a repressive gene marker, was,
however, comparable in the two populations (Figure 4A). Fur-
thermore, the DNA sequence, which has ten CpGs, was hypo-
methylated in both the Stella-GFP-positive and Stella-GFP-
negative/Pecam1-negative FACS-sorted cells (Figure 4B),
except for a slight increase in some of the latter cells. These
results indicate that the metastable expression of stella is regu-
lated by chromatin-based epigenetic changes, which is inde-
pendent of DNA methylation.As the histone modifications can be relatively plastic, we next
tested the responsiveness of Stella expression under a variety of
conditions. First, we found that the culture of ESCs in a chemi-
cally defined medium without embryonic fibroblast feeder cells
(MEFs), which are a source of signaling molecules that affect
ESCs (Chambers and Smith, 2004), resulted in almost complete
loss of Stella-GFP expression (Figure 4C). Notably, Stella-GFP
expression was, however, restored as before in more than
20% of the ESCs when they were returned to culture with
MEFs (Figure 4C). This clearly shows that the metastable state
of Stella-GFP expression is influenced by environmental cues,
one of which is signals from MEFs. Notably, Stella-GFP expres-
sion was also restored in response to 10 nM trichostatin A (TSA),
an inhibitor of histone deacetylase, but DNA5-azacytidine, an
inhibitor DNA methyltransferase, had no effect. Indeed, the
proportion of Stella-GFP-positive cells increased to 37.5% in
response to TSA. These ESCs also showed a striking phenotypic
change as they formed compact colonies, which is characteristic
of ESCs grown on MEFs (Figure 4D). These results demonstrate
that histone acetylation, but not DNAmethylation of Stella locus,
is one of the epigenetic modifications regulating expression of
Stella.
Functional Differences between the Subpopulations
of ESCs
Our studies above show that the ESCs consist of subpopulations
of cells that exhibit distinct gene expression profiles while being
in a metastable epigenetic state. The subpopulations were in
a constantly interchangeable state under conditions that
maintain them in an undifferentiated state. However, we decided
to investigate whether the Stella-positive/Pecam1-positive and
Stella-negative/Pecam1-negative cells exhibit distinct proper-
ties if they were forced to undergo differentiation. First, we
Cell Stem Cell 3, 391–401, October 9, 2008 ª2008 Elsevier Inc. 395
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bodies (EBs) and found that the Stella-negative/Pecam-negative
cells seldom formed EBs, whereas Stella-GFP-positive/Pe-
cam1-positive cells could do so readily as expected and as
judged by the detection of differentiation marker genes (data
not shown), which suggests a difference in the properties of
the two populations. Next, we cultured the two cell populations
with retinoic acid (RA) that induces mainly neuronal differentia-
tion. Q-PCR analysis showed that expression of early neuronal
lineage-marker genes, Sox1, Nestin, and Pax6, was enhanced
in Stella-GFP-negative/Pecam1-negative cells compared to
the levels of expression detected in Stella-GFP-positive/Pe-
cam1-positive cells (Figure 5A). This is not due to a difference
in the basal levels of expression of these genes in each popula-
tion, since Sox1 and Pax6 transcripts were rather lower in nonsti-
mulatedStella-GFP-negative/Pecam1-negative cells (Figure 5A).
These results demonstrate that the Stella-GFP-negative/
Pecam1-negative cells were more sensitive to the signal to un-
dergo differentiation, at least with respect to the response to
RA-induced differentiation.
Next we checked their response when each population was
cultured under conditions that are known to induce differentia-
tion of trophectoderm cells (TS medium). Surprisingly, the
Stella-GFP-negative/Pecam1-negative population readily ex-
hibited remarkable upregulation ofCdx2 gene expression, which
is a marker of trophoectoerm cells in pre- and peri-implantation
embryos, as well as of other markers of this lineage, such as
Hand1 and Dlx1 (Figure 5B). Immunofluorescence analysis also
showed that Cdx2 was clearly detectable in nuclei of these cells,
forming dense colonies, as well as in large nuclei of presumptive
trophoblast giant cells located around the periphery of differen-
tiating colonies (Figure 5C). Recently, evidence from pluripotent
stem cells derived from postimplantation epiblast cells (EpiSCs)
shows that these are alsomore capable of differentiation into tro-
phectoderm cells (Brons et al., 2007; Tesar et al., 2007). This is
consistent with our data showing that the Stella-negative/Pe-
cam1-negative ESCs are more like the epiblast cells. By con-
trast, the Stella-positive/Pecam1-positive cells failed to show
this response. This is consistent with the fact that ESCs generally
show a small number of differentiating trophectoderm cells when
cultured under TS cell conditions. Taken together, these results
demonstrate that Stella-negative cells possess functionally dis-
tinct properties, among which is a state that is permissive for
differentiation into trophectoderm cells that is also observed
with EpiSCs.
Comparisons between the State of Stella in ESCs
and EpiSCs
Based on our analysis, ESCs consist of a population of Stella-
GFP-negative/Pecam1-negative cells that are relatively closer
to the epiblast cells and share some of the differentiation poten-
tial with EpiSCs, a stem cell line from epiblast cells of postim-
plantation embryos. We therefore further characterized the
Stella-GFP-negative/Pecam1-negative ESCs by comparing
marker gene expression and epigenetic status of stella in
EpiSCs. As expected, we detected Fgf5 expression in EpiSCs,
but the levels were significantly higher compared to those in
the epiblast-like cells in ESCs (Figure 6A). By contrast, expres-
sions of stella, Pecam1, and Zfp42/Rex1 were negligible in
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unlike a lack of Pecam1 expression, we detected heterogeneous
expression of SSEA1 in EpiSCs (Figure 6C) consistent with sim-
ilar expression in the epiblast cells in vivo. Levels of Nanog and
Sox2 in EpiSCs are comparable to those in the epiblast-like cells
in ESCs (Figure 6A). These observations suggest that the Stella-
GFP-negative/Pecam1-negative population in ESCs represents
an intermediate state between ICM-like cells and the EpiSCs.
This was also supported by microarray analysis using single-
cell gene expression profile, which revealed that ESCs with low
Figure 5. Differentiation Potential of Stella-Positive and Stella-
Negative Populations
(A) Response to RA-induced differentiation and expression of neuronal
markers. Graphs show a representative Q-PCR analysis of Sox1, Nestin,
and Pax6 expression in FACS-sorted Stella-GFP-positive/Pecam1-positive
(black) and Stella-GFP-negative/Pecam1-negative (white) ESCs cultured
with RA as for days (d) as indicated. Samples at d0 were prepared immediately
after FACS sorting followed by RA induction.
(B) Expression of trophectoderm marker genes. Graph shows representative
Q-PCR analysis of Cdx2, Hand, and Dlx1 expression in each subpopulation,
as described in (A) when cultured under TS cell conditions. Repeated
Q-PCR analysis using different sets of sorted samples showed similar results
as shown in both (A) and (B).
(C) Enhanced expression of Cdx2 protein. Images are immunostaining of Cdx2
(green) and DAPI (blue) in each subpopulation cultured for 3 days under TS
conditions. Arrow and arrowhead indicate representative Cdx2-positive dense
colony and cells having large nuclei, respectively. Scale bar, 50 mm.
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(A) Q-PCR analysis of gene expression in EpiSCs, FACS-
sorted populations of Stella-GFP-positive and Stella-
GFP-negative/Pecam1-negative ESCs. Relative levels
of gene expression in EpiSCs were estimated by refer-
ence to the value of Gapdh.
(B) ChIP analysis of histone modifications in the stella lo-
cus of EpiSCs. Genomic DNAs were immunoprecipitated
from FACS-sorted EpiSCs with antibodies as indicated,
followed by Q-PCR analysis. Levels of histone modifica-
tions were estimated as indicated in Figure 4A.
(C) FACS analysis of Pecam1 and SSEA1 in EpiSCs. His-
tograms show expression of Pecam1 (left) and SSEA1
(right).
(D) Bisulfite sequencing profiles of DNA methylation in
the Stella locus in EpiSCs. CpG sequences are shown
with filled (methylated) and open (unmethylated) circles.
(E) Bisulfite sequencing profiles of LINE-1. Sequences
are shown with filled (methylated) and open (unmethy-
lated) circles. The numbers under the bisulfite sequenc-
ing profiles show the percentages of methylated CpG.
Gaps in the methylation profiles represent mutated or
missing CpG sites. The numbers under the bisulfite se-
quencing profiles show the percentages of methylated
CpG.1–401, October 9, 2008 ª2008 Elsevier Inc. 397
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when compared with ESCs with high expression of stella and
EpiSCs (Figure S2). In other words, cells with low expression of
stella were closer to the EpiSCs compared to the cells with
high expression of stella.
Next we compared the epigenetic status of stella locus in
EpiSCs with the situation in ESCs. Compared to epiblast-like
cells in ESCs, the levels of H3K9ac and H3K4me3 in EpiSCs
were considerably diminished (Figure 6B), whereas that of
H3K27me3 showed an increase. Most strikingly, the stella
Figure 7. Proposed Model for the Maintenance in ESCs Composed
of Distinct Cell Types in a Dynamic Equilibrium
(A) ESCs are represented as consisting of distinct subpopulations of cells,
each of which has a different combination of developmentally regulated genes
spanning between the ICM and epiblast-like phenotype. The mechanism that
drives ESCs from ICM to epiblast-like cells may be similar to that which regu-
lates the inherent developmental program from ICM of blastocysts to epiblast
of postimplantation embryos in vivo, but the mechanism involved in the re-
verse process of epiblast-like cells back to ICM-like cells suggests a dediffer-
entiation step (broken line); the mechanism regulating the latter is unknown.
The region representing self-renewal of ESCs is distinct from that which gov-
erns self-renewal of EpiSCs. Notably, DNA methylation of the stella locus is
one criteria that distinguishes ESCs from EpiSCs (see text for details).
(B) Distinct functional and epigenetic states of the two major subpopulations
detected in ESCs. Expression of stella in ESCs is regulated by distinct his-
tone-based epigenetic modifications. Stella-positive and Stella-negative sub-
populations also exhibit characteristic functional differences; the latter pos-
sess the potential for differentiation into trophectoderm cells (TE) but show
poor ability to form embryoid bodies (EB) from single cells as seen with
EpiSCs. By contrast, Stella-positive cells can readily form EBs from single cells
but show little if any tendency to differentiate into TE. (See text for details.)
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ure 6D). These results demonstrate that the epigenetic status
and regulation of stella in the epiblast-like ESC subpopulations
and EpiSCs differ significantly. Apart from the stella locus,
LINE1 sequences, a retrotransposable element that is widely
distributed in the genomic DNA, were also hypermethylated in
EpiSCs, whereas they were hypomethylated in both populations
from ESCs (Figure 6E), which demonstrates that DNA methyla-
tion takes place not only in the stella locus but also in genome-
wide regions. These observations are consistent with the fact
that de novo DNA methylation takes place in the pluripotent
cell population in vivo during peri-implantation development
(Kafri et al., 1992; Monk et al., 1987), which is essential for further
development (Li et al., 1992; Okano et al., 1999). DNA methyla-
tion at this stage is linked to the incipient differentiation of plurip-
otent cells involving developmentally regulated genes, one of
which is stella.
DISCUSSION
Single-cell analysis demonstrates that ESCs exhibit heterogene-
ity that spans across ICM to epiblast-like phenotypes. Whereas
expression of stella in ESCs represents one extreme of ICM-like
cells, the mutually exclusive expression of Fgf5 among Stella-
GFP-negative/Pecam1-negative cells represents the most epi-
blast-like cells. Thus, ESCs are not a homogeneous group of
self-renewing cells as they constantly fluctuate between ICM
and epiblast-like states with an apparent adherence to an inher-
ent program. Since the number of cells with stella transcripts ex-
ceeds those that exhibit endogenous Stella and Stella-GFP, it is
possible that translational regulationmechanismsmay be impor-
tant during self-renewal and pluripotency. The expression of
stella in ESCs is regulated by histone-based modifications,
which is responsive to environmental and epigenetic factors.
By contrast, stella in EpiSCs derived from the postimplantation
epiblast cells is repressed robustly by DNA methylation, which
denotes a barrier between the two types of pluripotent stem cells
(Figure 7A).
It was striking that the proportion of Stella-GFP-positive cells
in ESCs remained relatively constant, even after the culture of
Stella-GFP-positive/Pecam1-positive and Stella-GFP-negative/
Pecam1-negative cells separately, as they regenerated the ap-
propriate number of reciprocal cell types. However, the latter
were slower than the former in converting into the reciprocal
cell types. This is presumably because in the first case, the cells
are progressing along an inherent developmental program from
ICM- toward epiblast-like cells, while the converse represents
a ‘‘dedifferentiation’’ step that is contrary to the normal develop-
mental program. Our single-cell analysis also shows that cells
lacking in stella transcripts had exceedingly low levels ofPecam1
expression as well as lower levels of nanog expression. These
observations are broadly in agreement with the differential ex-
pression of Pecam1 in ESCs, where the Pecam1-negative cells
are predominantly epiblast-like cells (Furusawa et al., 2006;
Kemp et al., 2005). Furthermore, Pecam1-positive or Nanog-
positive cells constitute a relatively stable population of ESCs
(Chambers et al., 2007; Furusawa et al., 2006; Furusawa et al.,
2004), while the Pecam1-negative and Nanog-negative cells
are harder to convert back into their reciprocal counterparts.
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the proportion of Stella-GFP-positive cells was reversibly re-
sponsive to MEFs, which are a source of signaling molecules
that may in turn influence the intrinsic epigenetic state of re-
sponding cells (Ansel et al., 2003; Kang et al., 2005; van
Grunsven et al., 2005). Multiple signaling molecules, together
with the transcription and epigenetic factors, play an essential
role in maintaining pluripotency in ESCs (Chambers and Smith,
2004; Surani et al., 2007). We stress that the proportion of
Stella-GFP-positive cells could significantly exceed those we re-
port here, provided appropriate conditions exist that promote
the ICM-like phenotype. Indeed, ESCs cultured without MEFs
that were almost completely in an epiblast-like state showed
a very significant increase in Stella-GFP-positive cells in re-
sponse to TSA. Thus, TSA-induced reprogramming of ESCs
caused a significant shift toward an ICM-like state from a virtual
epiblast-like state prior to the treatment. Notably, the effect of
TSA was striking because it also induced a marked phenotypic
change in the ESCs colonies, which acquired an appearance
that is reminiscent of the colonies grown on MEFs. Consistently,
it was reported that the same concentration (10 nM) of TSA in-
hibited differentiation of ESCs when cultured without LIF (Lee
et al., 2004), although a significantly higher dosage of TSA in-
duced ESC differentiation (McCool et al., 2007). Thus, the bal-
ance between histone acetylation and deacetylation may be at
least one factor that may determine whether ESCs are in an
ICM-like or epiblast-like state.
The gene expression profile indicated that the stella-negative
ESCs are situated between ICM and fully developed epiblasts.
Under the culture conditions that maintain ESCs, the stella-neg-
ative cells might not be able to progress to the EpiSCs owing to
the extrinsic signals that force them back to the ICM-like state.
However, when Stella-GFP-negative/Pecam1-negative ESCs
were cultured under EpiSC condition, Fgf5 expression showed
a further increase (data not shown). More importantly, we dem-
onstrate that the Stella-positive and Stella-negative cells show
clear differences with respect to their potential for differentiation
(Figure 7B). Notably, the Stella-negative cells can differentiate
into trophectoderm cells, a property they share with EpiSCs.
Analysis of epigenetic status, however, clearly showed that
DNA methylation of the stella locus represents a boundary be-
tween ESCs and EpiSCs. EpiSCs, despite showing expression
of pluripotent marker genes including Oct4, Sox2, and Nanog,
are epigenetically quite distinct from ESCs, as they rarely con-
tribute to chimeras, and unlike ESCs, they exhibit an inactive
X chromosome (Tesar et al., 2007). Notably, the EpiSCs do not
exhibit an ICM-like state unlike ESCs, which can fluctuate freely
within the ‘‘self-renewal parameters’’ encompassed by the ICM
and epiblast-like states and where stella locus is hypomethy-
lated and its expression is regulated by chromatin-based modi-
fications (Figure 7A). Furthermore, this is consistent with the
evidence that de novo DNA methylation is not essential for
self-renewal of ESCs but is essential for their differentiation
(Chen et al., 2003; Lei et al., 1996).
Our preliminary evidence shows that the stella locus in EpiSCs
is subject to DNA demethylation only in the cells that undergo
specification into PGCs (K.H. and M.A.S., unpublished data),
consistent with the fact that Stella is only expressed in the
germ cell lineage after implantation (Saitou et al., 2002; Satoet al., 2002). This epigenetic change in the stella locus exclusively
in PGCs is probably an important hallmark of other significant
epigenetic reprogramming events in PGCs. Strikingly, these
epigenetic changes in PGCs confer the ability on early germ cells
to undergo dedifferentiation into pluripotent embryonic germ
cells, which resemble ESCs. EpiSCs themselves may lack the
ability to convert directly into ESCs with a population of ICM-
like cells.
In view of our findings, it is striking to note a virtual loss of stella
expression in ESCs with a null mutation in the gene encoding
methyl-CpG-binding domain protein 3 (Mbd3), which is a mem-
ber of the NuRD complex (Kaji et al., 2006). Reciprocally, the
Mbd3 null ESCs show high levels of Fgf5 expression, possibly
as they acquire a more epiblast-like character and grow inde-
pendently of LIF, although they are unable to differentiate.
Mbd3 is also essential for peri-implantaton development
in vivo. Similarly, Dicer null ESCs can be maintained without
LIF, but they are impaired in their ability to undergo differentiation
(Kanellopoulou et al., 2005; Murchison et al., 2005). We predict
that these mutant cells may be more epiblast-like and devoid
of Stella expression, and their differentiation is impaired because
of attenuated DNA methylation due to misexpression of de novo
DNA methyltransferases (Sinkkonen et al., 2008). Thus, the exit
from ESCs and loss of ICM-like stella-positive phenotype is cou-
pled with DNA methylation as represented by methylation of the
stella locus.
In conclusion, our study shows that ESCs are not a group of
uniform self-renewing cells, since they appear to be in ametasta-
ble state and shift between ICM- and epiblast-like states while
retaining pluripotency. This equilibrium can shift in either direc-
tion in response to a variety of factors, including epigenetic reg-
ulators. Analysis of Stella expression may be used to determine
the precise phenotypic state of different ESC lines and of the fac-
tors, including epigenetic regulators, that affect its expression.
The proportion of Stella-GFP-positive, and therefore ICM-like,
cells in ESC cultures is a sensitive indicator of optimal environ-
mental or epigenetic modulators that promote this phenotypic
state. Further studies may also reveal the precise role of Stella
in the derivation and maintenance of ESCs.
EXPERIMENTAL PROCEDURES
Cell Culture
ESCs were grown in ESC medium (DMEM/F12, Invitrogen; supplemeted with
15% fetal calf serum, 1 mM glutamine, 100 u/ml penicillin/streptomycin,
0.1 mM b-mercaptoethanol, and 1000 u/ml LIF) on mitomycin C-treated
MEFs, unless specifically mentioned. For clonal culture analysis, 500 FACS-
sorted single ESCs were spread on MEFs seeded on 6 cm tissue culture
dish. After 5 days of culture, the number of colonies on the dish was counted,
and then the colonies were picked up, trypsinised, and transferred into 24-well
dishes. At 4 days after picking the colonies up, Stella-GFP-positive cells were
analyzed by FACS. To establish MEF-independent stella-gfp ESCs, the ESC
line was cultured in Clonal Grade Medium (Chemicon) for 10–14 days and
then maintained in knockout DMEM (Invitrigen) containing 20% of knockout
serum replacement, 1mMglutamine, 100 u/ml penicillin/streptomycin, 0.1mM
b-mercaptoethanol, and 1000 u/ml LIF. The KSR-containingmediumwas used
as the chemically defined medium. For differentiation analysis, FACS-sorted
cells (1 3 105cells/ml) were cultured in the chemically defined medium with
RA (1 mM) or in TS medium with supernatant from medium cultured with
MEFs (Tanaka et al., 1998). For EB formation, cells were seeded into Petri
dish in medium without LIF. EpiSCs were cultured in N2B27 supplemented
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12 ng/ml of bFGF (Invitrogen). Both ESCs and EpiSCs were cultured in 5%
CO2/95% air at 37
C.
FACS and Immunofluorescence Analysis
For FACS analysis, single-cell suspension was stained with R-Phycoerythrin-
conjugated rat anti-Pecam1 (BD Pharmingen) and anti-SSEA1 antibody (TG1).
The stained cells were analyzed and sorted by FACSort with CELLQUEST soft-
ware (BDBiosciences) and FACSAria (BDBiosciences), respectively. Immuno-
fluorescence analysis of cells was performed essentially as described (de
Sousa Lopes et al., 2004; Ohinata et al., 2005). The antibodies used were rab-
bit anti-PGC7/Stella, mouse anti-CDX2 (Cdx2-88, BioGenex), and rat anti-GFP
(Nacalai tesque). All secondary antibodies used were Alexa Fluor highly
crossed adsorbed (Molecular Probes). Samples were mounted in Vectashield
with DAPI (Vector). Immunofluorescence signals were detected by an Olym-
pus IX71 inverted microscope or by a Bio-Rad (Hercules, CA) Radiance
2000 confocal microscope.
RT-PCR Analysis
For Q-PCR analysis using fractionated cells, total RNA was extracted from
sorted ESCs and EpiSCs by using Trizol (Sigma). cDNAwas synthesized using
Superscript II and oligo d(T) primer (Invitrogen) followed by Q-PCR reaction
using SYBR Green master mix (QIAGEN) and specific primers. For Q-PCR
using single cells, single-cell cDNA preparation was performed as described
in detail previously (Kurimoto et al., 2007). The putative number of transcripts
was estimated by referring in vitro-transcribed control transcripts (Kurimoto
et al., 2007). cDNAs was used for each 20 ml Q-PCR reaction with SYBR Green
MasterMix (QIAGEN) and 1 mMof each primer andwas amplified under the fol-
lowing conditions: 95C for 10min and then 40 cycles of 95C for 15 s and 60C
for 1 min. Primer sequences used in this study are available on request.
CHIP Analysis
FACS-sorted 106 ESCs or EpiSCs and 33 107 3T3 cells, as carrier cells, were
fixed with 1% formaldehyde, lysed, and sonicated to obtain 200–500 bp DNA
fragments conjugated with nucleosomes. The sonicated lysates were immu-
noprecipitated with rabbit polyclonal anti-acetyl H3K9 (Abcam), mouse mono-
clonal anti-trimethyl H3K4 (Abcam), or rabbit polyclonal anti-tri-methyl H3K27
(Abcam) antibodies that were in advance reacted with secondary antibodies
conjugated with magnetic beads (Dynal). After incubation with each antibody
for 1 day, immunoprecipitants were recovered and washed by using magnetic
stand (Dynal). Then DNA fragments contained in the immunoprecipitants were
purified by incubation with Proteinase K. The DNA fragments were subjected
to Q-PCR. Whole-cell lysates before incubation with antibodies were used as
input. DNA fragments from whole lysates and immunoprecipitants were sub-
ject to pre-PCR at 15 and 20 cycles, respectively. After purifying the pre-PCR
products by PCR purification kit, 1 ml of the product was used for Q-PCR re-
action 1 mMof nested primers. Negative control samples using only secondary
antibodies conjugated with magnetic beads showed similar levels of very low
background or no detectable background. Primer sequences used in this
study are available on request.
Bisulfite Sequence Analysis
Bisulphite sequence analysis of the genomic DNA isolated from FACS-sorted
ESCs was carried out by EpiTect Bisulfite Kit (QIAGEN). The primer sequences
and PCR conditions for amplification of LINE1 and IAP sequences are previ-
ously described (Lane et al., 2003). The PCR products were cloned using
pGEM-T Easy Vector System I (Promega) and were sequenced by Cogenics.
SUPPLEMENTAL DATA
The Supplemental Data include two figures, Supplemental Experimental Pro-
cedures, and Supplemental References and can be found with this article
online at http://www.cellstemcell.com/cgi/content/full/3/4/391/DC1/.
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